Research Results in Pharmacology (Jun 2019)

Pharmacological modulation of cell functional activity with valproic acid and erythropoietin

  • Polina A. Golubinskaya,
  • Marina V. Sarycheva,
  • Svetlana Y. Burda,
  • Maksim V. Puzanov,
  • Natalya A. Nadezhdina,
  • Vladimir F. Kulikovskiy,
  • Sergey V. Nadezhdin,
  • Michail V. Korokin,
  • Yuriy E. Burda

DOI
https://doi.org/10.3897/rrpharmacology.5.34710
Journal volume & issue
Vol. 5, no. 2
pp. 89 – 99

Abstract

Read online Read online Read online

Introduction: Valproic acid (VA) is carboxylic acid with a branched chain, which is used as an antiepileptic drug. Valproic acid influence on cells in vivo: VA, which is an antiepileptic drug, is also a teratogen, which causes defects of a neural tube and an axial skeleton, although the mechanisms are not yet fully clear. Valproic acid influence on mesenchymal stem cells (MSC) in vitro: It is shown that valproic acid reduces the intracellular level of oxygen active forms. Valproic acid effect on tumor cells: VA inhibits tumor growth through several mechanisms, including the cell cycle stop, differentiation induction and inhibition of growth of tumor vessels. Valproic acid influence on enzymes: It affects mainly GSK-3. Valproic acid influence on animals’ cells: It is shown that VA can significantly improve an ability to develop in vitro and improve nuclear reprogramming of embryos. Erythropoietin (EPO): Is an hypoxia-induced hormone and a cytokine, which is necessary for normal erythropoiesis. EPO is widely used in in vitro experiments. Conclusion: Thus, the influence of VA and EPO on cells can be used in cell technologies.